Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer
This study is ongoing, but not recruiting participants.
Sponsor:
Zhimin Shao
Collaborator:
Roche Pharma AG
Information provided by (Responsible Party):
Zhimin Shao, Fudan University
ClinicalTrials.gov Identifier:
NCT01428414
First received: August 28, 2011
Last updated: August 21, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2015 |
| Estimated Primary Completion Date: | August 2014 (Final data collection date for primary outcome measure) |